Results 21 to 30 of about 583,528 (304)

Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia

open access: yesCritical Care, 2018
Background This study aimed to evaluate the accuracy of procalcitonin (PCT) serum concentrations to diagnose Gram-negative bacteremia and the association of PCT serum concentrations with more specific pathogens and the focus of infection.
Daniel O. Thomas-Rüddel   +6 more
doaj   +1 more source

Common Variants of TLR1 Associate with Organ Dysfunction and Sustained Pro- Inflammatory Responses during Sepsis [PDF]

open access: yes, 2010
Background: Toll-like receptors (TLRs) are critical components for host pathogen recognition and variants in genes participating in this response influence susceptibility to infections.
Pino Yanes, Maria   +38 more
core   +2 more sources

Sepsis beim Hund: Interleukin-6 als prognostischer Parameter [PDF]

open access: yes, 2007
Wie auch in der Humanmedizin stellen Sepsis und SIRS den behandelnden Arzt in der Veterinärmedizin vor eine große Herausforderung. Eine optimale therapeutische Intervention setzt besonders die Früherkennung dieser Erkrankungen und damit auch die ...
Rau, Stefanie Maria
core   +1 more source

Delayed wound repair in sepsis is associated with reduced local pro-inflammatory cytokine expression [PDF]

open access: yes, 2013
Sepsis is one of the main causes for morbidity and mortality in hospitalized patients. Moreover, sepsis associated complications involving impaired wound healing are common.
Marzi, Ingo   +15 more
core   +2 more sources

Sepsis

open access: yesSeminars in Oncology Nursing, 1999
To review infection and sepsis in patients with cancer and to provide an overview of controversies and research-based practices of infectious complications and management strategies.Research studies, review articles, web sites, and consensus documents.Traditional assumptions about infection and its optimal management are redefined by research regarding
openaire   +2 more sources

Activity and Outcomes of a Multidisciplinary Sepsis Unit: Fifty Thousand Consultations over Thirteen Years

open access: yesAntibiotics
Background. Sepsis is a leading, time-dependent cause of in-hospital death, and guidelines now prioritize organized care such as code-sepsis protocols.
Marcio Borges-Sa   +9 more
doaj   +1 more source

Iron status and the risk of sepsis and severe COVID-19: a two-sample Mendelian randomization study

open access: yesScientific Reports, 2022
Observational studies have indicated an association between iron status and risk of sepsis and COVID-19. We estimated the effect of genetically-predicted iron biomarkers on risk of sepsis and risk of being hospitalized with COVID-19, performing a two ...
Randi Marie Mohus   +8 more
doaj   +1 more source

All that seems sepsis is not sepsis

open access: yesIndian Journal of Critical Care Medicine, 2013
Catastrophic antiphospholipid antibody syndrome (CAPS) resembles severe sepsis in its acute presentation, with features of systemic inflammatory response syndrome (SIRS) leading to multiple organ dysfunction. Infections are the best known triggers of CAPS. This emphasizes the need for early diagnosis and aggressive treatment as the mortality is as high
Guleria, Vivek S.   +3 more
openaire   +3 more sources

Biomarkers for Sepsis [PDF]

open access: yesBioMed Research International, 2014
Bloodstream infections are a major concern because of high levels of antibiotic consumption and of the increasing prevalence of antimicrobial resistance. Bacteraemia is identified in a small percentage of patients with signs and symptoms of sepsis. Biomarkers are widely used in clinical practice and they are useful for monitoring the infectious process.
Henriquez-Camacho, Cesar, Losa, Juan
openaire   +3 more sources

Is Drotrecogin alfa (activated) for adults with severe sepsis, cost-effective in routine clinical practice? [PDF]

open access: yes, 2011
INTRODUCTION: Previous cost-effectiveness analyses (CEA) reported that Drotrecogin alfa (DrotAA) is cost-effective based on a Phase III clinical trial (PROWESS).
Brian H Cuthbertson   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy